recent publications

• academic article

  • Tang, B., Capitao, C., Dean, B., Thomas, E. A. Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia Psychiatry Research  2012 196:201-206  DOI:10.1016/j.psychres.2011.09.026  PMID:22397921  PMCID:PMC3361581
  • Tang, B., Dean, B., Thomas, E. A. Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders Translational Psychiatry  2011 1:e64  DOI:10.1038/tp.2011.61  PMID:22832356  PMCID:PMC3305989
  • Udawela, M., Scarr, E., Hannan, A. J., Thomas, E. A., Dean, B. Phospholipase c beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness Australian and New Zealand Journal of Psychiatry  2011 45:140-147  DOI:10.3109/00048674.2010.533364  PMID:21091263
  • Torkamani, A., Dean, B., Schork, N. J., Thomas, E. A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia Genome Research  2010 20:403-412  DOI:10.1101/gr.101956.109  PMID:20197298  PMCID:PMC2847743
  • Gibbons, A. S., Thomas, E. A., Dean, B. Regional and duration of illness differences in the alteration of ncam-180 mrna expression within the cortex of subjects with schizophrenia Schizophrenia Research  2009 112:65-71  DOI:10.1016/j.schres.2009.04.002  PMID:19411161  PMCID:PMC2722680
  • Narayan, S., Head, S. R., Gilmartin, T. J., Dean, B., Thomas, E. A. Evidence for disruption of sphingolipid metabolism in schizophrenia Journal of Neuroscience Research  2009 87:278-288  DOI:10.1002/jnr.21822  PMID:18683247  PMCID:PMC2606914
  • Narayan, S., Tang, B., Head, S. R., Gilmartin, T. J., Sutcliffe, J. G., Dean, B., Thomas, E. A. Molecular profiles of schizophrenia in the cns at different stages of illness Brain Research  2008 1239:235-248  DOI:10.1016/j.brainres.2008.08.023  PMID:18778695  PMCID:PMC2783475
  • Gibbons, A. S., Scarr, E., McOmish, C. E., Hannan, A. J., Thomas, E. A., Dean, B. Regulator of g-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia Australian and New Zealand Journal of Psychiatry  2008 42:740-745  PMID:18622782
  • Dean, B., Laws, S. M., Hone, E., Taddei, K., Scarr, E., Thomas, E. A., Harper, C., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E., Martins, R. N. Increased levels of apolipoprotein e in the frontal cortex of subjects with schizophrenia Biological Psychiatry  2003 54:616-622  DOI:10.1016/s0006-3223(03)00075-1  PMID:13129656
  • Thomas, E. A., Laws, S. M., Sutcliffe, J. G., Harper, C., Dean, B., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E., Martins, R. N. Apolipoprotein d levels are elevated in prefrontal cortex of subjects with alzheimer's disease: No relation to apolipoprotein e expression or genotype Biological Psychiatry  2003 54:136-141  DOI:10.1016/s0006-3223(02)01976-5  PMID:12873803
  • Thomas, E. A., Dean, B., Scarr, E., Copolov, D., Sutcliffe, J. G. Differences in neuroanatomical sites of apod elevation discriminate between schizophrenia and bipolar disorder Molecular Psychiatry  2003 8:167-175  DOI:10.1038/sj.mp.4001223  PMID:12610649
  • Thomas, E. A., Dean, B., Pavey, G., Sutcliffe, J. G. Increased cns levels of apolipoprotein d in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders Proceedings of the National Academy of Sciences of the United States of America  2001 98:4066-4071  DOI:10.1073/pnas.071056198  PMID:11274430  PMCID:PMC31180